title: Efficacy of vaginal spaying and anabolic implants on growth and carcass characteristics in beef heifers.
abstract: Ninety crossbred beef heifers averaging 260 kg were blocked by weight and allotted randomly to 15 pens of six heifers each, with three replicates per treatment. The treatments were spayed heifers (S); intact heifers (I); S + Synovex-H7 (SH); I + Synovex-H (IH); and S + Synovex-S7 (SS). The heifers were spayed vaginally with a Willis instrument; intact heifers were rectally palpated for reproductive soundness. Heifers were fed a growing diet (55 d), re-implanted and subsequently fed a finishing ration (73 or 101 d). All heifers were observed for estrus daily at approximately 0600 and 2000 until d 69. A jugular vein blood sample was obtained from each heifer on d 48, 55, 62 and 69 for blood progesterone analysis. Results of blood progesterone analysis and reproductive tract examination indicated that two spayed heifers were incompletely spayed, a 96% success rate. The SH and SS heifers continued to exhibit estrous behavior despite being successfully spayed. Heifers implanted with Synovex-H had greater (P less than .01) ADG and were more efficient (P less than .03) than nonimplanted heifers. The SS heifers had greater ADG (P less than .05) during the finishing phase than SH heifers, but no advantage of SS over SH was apparent during the growing phase. The overall ADG response to implantation was fourfold greater (P less than .07) in the spayed heifers than in the intact heifers (32 vs 8%). Heifers implanted with Synovex-H had greater adjusted hot carcass weight (P less than .02) and ribeye area (P less than .002) than nonimplanted heifers. For adjusted live weight and ribeye area, the response to implantation was approximately threefold greater in the spayed heifer than the intact heifer. These results demonstrate that spaying and implanting heifers can increase rates and efficiency of gain even though behavioral estrus is not eliminated.
authors.affiliation: University of Idaho, Moscow 83843.
authors.forename: M J
authors.initials: MJ
authors.lastname: Garber
authors.forename: R A
authors.initials: RA
authors.lastname: Roeder
authors.forename: J J
authors.initials: JJ
authors.lastname: Combs
authors.forename: L
authors.initials: L
authors.lastname: Eldridge
authors.forename: J C
authors.initials: JC
authors.lastname: Miller
authors.forename: D D
authors.initials: DD
authors.lastname: Hinman
authors.forename: J J
authors.initials: JJ
authors.lastname: Ney
mesh_terms: D000818:Animals; D001823:Body Composition; D002417:Cattle / Q000254:growth & development* / Q000601:surgery; D004338:Drug Combinations / Q000494:pharmacology; D004343:Drug Implants; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D005260:Female; D016014:Linear Models; D010052:Ovariectomy / Q000662:veterinary*; D011374:Progesterone / Q000097:blood / Q000494:pharmacology*; D011897:Random Allocation; D013739:Testosterone / Q000494:pharmacology*; D015430:Weight Gain
chemical_list: D004338:Drug Combinations; D004343:Drug Implants; C046521:estradiol benzoate, testosterone propionate drug combination; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; C025370:estradiol benzoate, progesterone drug combination